Table of Contents
Pharmacy, Volume 8, Issue 2 (June 2020) – 60 articles
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
- You may sign up for e-mail alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Cover Story (view full-size image) Inflammatory bowel disease (IBD) is a term used to describe a group of chronic intestinal [...] Read more. Inflammatory bowel disease (IBD) is a term used to describe a group of chronic intestinal inflammatory diseases with a range of debilitating symptoms that are generally relapsing and remitting along with complications requiring hospitalisation and/or surgeries. Managing patients with a chronic condition, such as inflammatory bowel disease (IBD), requires a multidisciplinary approach. Numerous studies have outlined the roles of pharmacists in chronic disease management within a multidisciplinary approach, yet there is no available literature on the role of pharmacists in IBD management. The pharmacist might be the first point of contact for IBD patients with initial symptoms or relapsing flares and, therefore, we conducted a survey to explore pharmacists’ confidence in and potential barriers to managing IBD and assess the impact of IBD education on their confidence in IBD management. View this paper